Gary Tin

679 total citations
9 papers, 241 citations indexed

About

Gary Tin is a scholar working on Computational Theory and Mathematics, Molecular Biology and Pharmacology. According to data from OpenAlex, Gary Tin has authored 9 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Computational Theory and Mathematics, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Gary Tin's work include Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Alzheimer's disease research and treatments (2 papers). Gary Tin is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Alzheimer's disease research and treatments (2 papers). Gary Tin collaborates with scholars based in Canada, Austria and United States. Gary Tin's co-authors include Praveen P. N. Rao, Tarek Mohamed, Arash Shakeri, Michael A. Beazely, Georg E. Winter, Matthias Hinterndorfer, Marko Cigler, Elvin D. de Araujo, Patrick T. Gunning and Kevin Dong and has published in prestigious journals such as Alzheimer s & Dementia, Bioorganic & Medicinal Chemistry Letters and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Gary Tin

9 papers receiving 238 citations

Peers

Gary Tin

PHYSI

PHARM

MB

CTM

OC

Ichiro Hijikuro Japan

Paola Marzullo Italy

Seyyed Abolghasem Ghadami Iran

Arash Shakeri Canada

Jennifer Mayes United Kingdom

Sara García‐Viñuales Italy

Jiaxin Yu China

Pham Dinh Quoc Huy Poland

Akash Marathakam India

Yipeng Pang China

Ichiro Hijikuro Japan

Gary Tin

101 ×0.9

PHYSI

92 ×1.0

PHARM

141 ×2.1

MB

52 ×0.8

CTM

150 ×2.7

OC

Citations per year, relative to Gary Tin Gary Tin (= 1×) peers Ichiro Hijikuro

Countries citing papers authored by Gary Tin

Since Specialization

Citations

This map shows the geographic impact of Gary Tin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Tin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Tin more than expected).

Fields of papers citing papers by Gary Tin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Tin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Tin. The network helps show where Gary Tin may publish in the future.

Co-authorship network of co-authors of Gary Tin

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Tin. A scholar is included among the top collaborators of Gary Tin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Tin. Gary Tin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tin, Gary, Marko Cigler, Matthias Hinterndorfer, et al.. (2024). Discovery of a DCAF11-dependent cyanoacrylamide-containing covalent degrader of BET-proteins. Bioorganic & Medicinal Chemistry Letters. 107. 129779–129779. 10 indexed citations

2.

Colas, Claire, Anna Koren, Fabian Offensperger, et al.. (2023). Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors. Cell chemical biology. 30(8). 953–964.e9. 4 indexed citations

3.

Rao, Praveen P. N., et al.. (2020). Drug repurposing for Alzheimer’s disease: Selective serotonin reuptake inhibitors. Alzheimer s & Dementia. 16(S9). 1 indexed citations

4.

Araujo, Elvin D. de, et al.. (2018). A functional in vitro assay for screening inhibitors of STAT5B phosphorylation. Journal of Pharmaceutical and Biomedical Analysis. 162. 60–65. 7 indexed citations

5.

Tin, Gary, et al.. (2018). Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid. ACS Chemical Neuroscience. 10(1). 226–234. 20 indexed citations

6.

Mohamed, Tarek, Arash Shakeri, Gary Tin, & Praveen P. N. Rao. (2016). Structure–Activity Relationship Studies of Isomeric 2,4-Diaminoquinazolines on β-Amyloid Aggregation Kinetics. ACS Medicinal Chemistry Letters. 7(5). 502–507. 19 indexed citations

7.

Tin, Gary, et al.. (2015). Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease. MedChemComm. 6(11). 1930–1941. 38 indexed citations

8.

Rao, Praveen P. N., et al.. (2015). Curcumin Binding to Beta Amyloid: A Computational Study. Chemical Biology & Drug Design. 86(4). 813–820. 105 indexed citations

9.

Mohamed, Tarek, et al.. (2013). Selective inhibition of human acetylcholinesterase by xanthine derivatives: In vitro inhibition and molecular modeling investigations. Bioorganic & Medicinal Chemistry Letters. 23(15). 4336–4341. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact